CPRX Hedge Fund Ownership (Q1 2026)

Catalyst Pharmaceuticals Inc (CPRX)

375 + Investors. Track Smart Money conviction in CPRX. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — CPRX

Based on 379 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q

For 2 consecutive quarters, more hedge funds added CPRX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

379 hedge funds hold CPRX right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

📶

Steady growth — +6% more funds vs a year ago

fund count last 6Q

+21 new funds entered over the past year (+6% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.

🟡

Slight buying edge — 54% buying

202 buying172 selling

Last quarter: 202 funds bought or added vs 172 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

⚠️

Fewer new buyers each quarter (-12 vs last Q)

new funds entering per quarter

Funds opening this position for the first time: 49 → 51 → 69 → 57. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.

🔒

52% of holders stayed for 2+ years

■ 52% conviction (2yr+) ■ 25% medium ■ 23% new

196 out of 379 hedge funds have held CPRX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

📈

Growing discovery — still being found

72 → 49 → 51 → 69 → 57 new funds/Q

New funds entering each quarter: 49 → 51 → 69 → 57. A growing number of institutions are discovering CPRX each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.

🏛️

Veteran-anchored — 58% veterans vs 29% newcomers

■ 58% veterans ■ 13% 1-2yr ■ 29% new

Entry-cohort mix of 387 holders: 226 (58%) are 2+ year veterans, 49 entered 1–2 years ago, and 112 (29%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.

🏆

Elite ownership — 59% AUM from top-100 funds

59% from top-100 AUM funds

58 of 379 holders are among the 100 largest funds by AUM, controlling 59% of total institutional value in CPRX. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

3.7

out of 10

Low Exit Risk

Exit risk score 3.7/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q1)	Prior (2025 Q4)	Change
Funds Holding	375	370	1.35%
13F Shares	104M	104M	-0.37%
Total Value	$2.49B	$2.40B	4.02%
New Positions	55	69	-14
Increased Positions	145	119	+26
Closed Positions	50	53	-3
Reduced Positions	118	127	-9
Total Calls	4	2	100.0%
Total Puts	4	2	100.0%
PUT/CALL Ratio	1.0	1.0	Neutral

Metric

All 13F Filers (2026 Q1)

Prior (2025 Q4)

Change

Funds Holding

375

370

1.35%

13F Shares

104M

-0.37%

Total Value

$2.49B

$2.40B

4.02%

New Positions

-14

Increased Positions

145

119

+26

Closed Positions

-3

Reduced Positions

118

127

-9

Total Calls

100.0%

Total Puts

100.0%

PUT/CALL Ratio

1.0

Neutral

Institutional Holders (2026 Q2)

375 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in CPRX. Verified SEC 13F-HR filings.

QUARTER:

2026 Q2 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 CPRX holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Versor Investments LP	5.04%	76,286	$2.4M
2	Gables Capital Management INC.	4.76%	419,181	$13.2M
3	JW Asset Management, LLC	3.82%	388,392	$12.2M
4	Nexpoint Asset Management, L.P.	3.37%	1,602,557	$50.4M
5	Water Island Capital LLC	2.73%	933,819	$29.3M
6	Chicago Capital Management, LLC	2.61%	122,650	$2.9M
7	Harvest Management LLC	1.85%	150,000	$4.7M
8	Kintayl Capital LP	1.43%	114,111	$3.6M
9	Sagefield Capital LP	1.33%	569,481	$17.9M
10	Bridge City Capital, LLC	1.10%	152,684	$4.8M
11	Third Avenue Management LLC	1.06%	210,161	$6.6M
12	Clark Estates Inc/Ny	0.83%	113,918	$3.6M
13	First Trust Capital Management L.P.	0.76%	416,209	$13.1M
14	Melqart Asset Management (UK) Ltd	0.74%	247,556	$7.8M
15	GABELLI & Co INVESTMENT ADVISERS, INC.	0.73%	159,003	$5.0M
16	AlphaCentric Advisors LLC	0.63%	23,622	$742K
17	Polar Asset Management Partners Inc.	0.60%	1,150,300	$36.2M
18	Kennedy Capital Management LLC	0.48%	856,609	$26.9M
19	Linden Thomas Advisory Services, LLC	0.45%	176,004	$5.5M
20	Systematic Financial Management LP	0.42%	667,883	$21.0M
21	Abc Arbitrage SA	0.40%	117,681	$3.7M
22	Credit Industriel Et Commercial	0.39%	193,503	$6.1M
23	Wakefield Asset Management LLLP	0.38%	53,081	$1.7M
24	AQR Arbitrage LLC	0.30%	674,223	$21.2M
25	WINTON GROUP Ltd	0.29%	287,736	$9.0M

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Catalyst Pharmaceuticals Inc (CPRX)

What does the Smart Money Trend signal show for CPRX?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added CPRX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for CPRX?

Slight buying edge — 54% buying: Last quarter: 202 funds bought or added vs 172 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for CPRX holders?

Elite ownership — 59% AUM from top-100 funds: 58 of 379 holders are among the 100 largest funds by AUM, controlling 59% of total institutional value in CPRX. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held CPRX?

52% of holders stayed for 2+ years: 196 out of 379 hedge funds have held CPRX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Catalyst Pharmaceuticals Inc (CPRX)

Smart Money Signals — CPRX

Buying streak — 2 quarters in a row

At the ownership peak (100% of max)

Steady growth — +6% more funds vs a year ago

Slight buying edge — 54% buying

Fewer new buyers each quarter (-12 vs last Q)

52% of holders stayed for 2+ years

Growing discovery — still being found

Veteran-anchored — 58% veterans vs 29% newcomers

Elite ownership — 59% AUM from top-100 funds

Institutional Sentiment Summary — CPRX

Hedge Fund Ownership: CPRX

Market Analysis: CPRX

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: CPRX

Hedge Fund Positioning: CPRX

Statistics: CPRX

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Catalyst Pharmaceuticals Inc (CPRX)

Welcome to 13Foresight!